Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) Pathology

NCT ID: NCT00687752

Last Updated: 2008-06-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

310 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-05-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

310 singleton pregnancies (22-35 weeks) enrolled into the study. We assessed sonographically the fetal larynx in an axial plane through the mandible and observed the fetal deglutition movements .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

310 singleton pregnancies (22-35 weeks) enrolled into the study. We assessed sonographically the fetal larynx in an axial plane through the mandible and observed the fetal deglutition movements .We encountered two cases of hydramnios were no deglutition movements could be noted. In all other cases the deglutition was normal. The motivation to conduct the current observational prospective study was to assess whether there is a link between absence of fetal deglutition and CNS pathology of the fetus. In the first case the fetus deceased at 35 weeks of gestation; obduction was declined by the parents. In the second case caesarian section at 33 weeks was carried out recently due to fetal distress. The infant is still in uncapable of swallowing and there for is under investigation at the neonatal center of our hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hydramnios

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

fetal deglutition larynx fetal CNS pathology sonography hydramnios

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

hydramnios

No interventions assigned to this group

2

normal

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* singleton pregnancy(22-35 weeks)

Exclusion Criteria

* positive toxoplasmosis screening,drug and/or antidepressants addiction.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hippocration General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

2nd department OB/GYN Hippocration General Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

THEOHARIS A TANTANASIS, ASSIST PROF

Role: PRINCIPAL_INVESTIGATOR

2nd dept OB/GYN ARISTOTLE UNIV. THESSALONIKI GREECE

JOHN M TZAFETTAS, PROF

Role: STUDY_CHAIR

2nd dept OBGYN ARISTOTLE UNIV. THESSALONIKI GREECE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hippokration General Hospital

Thessaloniki, THESSALONIKI, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

27052008

Identifier Type: -

Identifier Source: org_study_id